Cargando…
Network-Based Biomarkers in Alzheimer’s Disease: Review and Future Directions
By 2050 it is estimated that the number of worldwide Alzheimer’s disease (AD) patients will quadruple from the current number of 36 million people. To date, no single test, prior to postmortem examination, can confirm that a person suffers from AD. Therefore, there is a strong need for accurate and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912507/ https://www.ncbi.nlm.nih.gov/pubmed/24550828 http://dx.doi.org/10.3389/fnagi.2014.00012 |